Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review

The success of cancer immunotherapy with immune checkpoint blockade (ICB) has demonstrated the importance of targeting a preexisting immune response in a broad spectrum of tumors. This is particularly novel and relevant for less immunogenic tumors, such as breast cancer (BC), where the efficacy of I...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transl Oncol
Auteurs principaux: Pellegrino, B., Musolino, A., Llop-Guevara, A., Serra, V., De Silva, P., Hlavata, Z., Sangiolo, D., Willard-Gallo, K., Solinas, C.
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press 2020
Sujets:
Review article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948367/
https://ncbi.nlm.nih.gov/pubmed/31901781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.10.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires